Jianmin Pharmaceutical Group Co Ltd (600976) — Long-term Investment Intensity
Jianmin Pharmaceutical Group Co Ltd (600976) has a Long-term Investment Intensity of 12.7% as of September 2019. Long-term investments of CN¥233.19 Million represent 12.7% of total assets of CN¥1.83 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Jianmin Pharmaceutical Group Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Jianmin Pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Jianmin Pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 12.7%, reflecting long-term investments of CN¥233.19 Million against total assets of CN¥1.83 Billion CNY. For the complete balance sheet picture, see Jianmin Pharmaceutical Group Co Ltd total assets.
Annual Long-term Investment Intensity for Jianmin Pharmaceutical Group Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Jianmin Pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Jianmin Pharmaceutical Group Co Ltd for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 13.4% | CN¥230.21 Million | CN¥1.72 Billion | ▲ +3.2 pp |
| 2017 | 10.2% | CN¥196.20 Million | CN¥1.92 Billion | ▲ +2.2 pp |
| 2016 | 8.0% | CN¥145.37 Million | CN¥1.81 Billion | ▲ +2.6 pp |
| 2015 | 5.4% | CN¥86.52 Million | CN¥1.60 Billion | — |